Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • NKE vs GSK✓SelectedUSD · GSKNKE vs GSK performance historyLatest closeAs of-4.11%11/20
Stock and ETF performance explorer

NKE vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+5,267.8%
GSK return
+1,644.3%
Excess return
+3,623.5%
Maximum drawdown
-79.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.1%-0.1%-4.0%-4.1%
7D-13.3%-5.3%-8.0%-11.8%
30D-12.3%-3.7%-8.6%-11.1%
3M-17.3%-7.3%-10.0%-15.2%
6M-24.0%-4.2%-19.8%-23.1%
YTD-47.0%+0.9%-47.8%-47.4%
1Y-44.6%+7.3%-51.9%-46.2%
3Y-66.8%+52.7%-119.5%-71.8%
5Y-79.4%+40.1%-119.5%-82.2%
10Y-25.5%+98.7%-124.2%-43.0%
All+5,267.8%+1,644.3%+3,623.5%+1,663.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling